Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Kiadis acquires CytoSen Therapeutics

Executive Summary

Kiadis Pharma Netherlands BV agreed to issue 1.94mm of its common shares (valued at $18.7mm based on the 10-day market average) to acquire privately held cell therapy firm CytoSen Therapeutics Inc.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Stock
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register